AxoGen (NASDAQ: AXGN) reported Q3 EPS of ($0.06), in-line with the analyst estimate of ($0.06). Revenue for the quarter came in at $16 million versus the consensus estimate of $15.59 million.

Guidance:

Sees FY 2017 revenues up 40%

Sees FY 2018 revenues up 40%

For earnings history and earnings-related data on AxoGen (AXGN) click here.